Company Filing History:
Years Active: 2003
Title: Inventor Spotlight: Christian Burks
Introduction
Christian Burks is an innovative inventor based in Berkeley, California. With a focus on the field of biotechnology, he has made significant contributions towards understanding and manipulating invertebrate TWIK channels.
Latest Patents
Burks holds a patent for "Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use." This patent details the isolation of Tandem pore domain weak inward rectifying K (TWIK) channel nucleic acids and proteins derived from Leptinotarsa. The invention opens pathways for genetic modifications in metazoan invertebrate organisms, including insects, coelomates, and pseudocoelomates. Burks’ work enables the expression or mis-expression of TWIK channels, which can be critical for assay screenings to identify potential pesticidal agents or therapeutics that target TWIK channel proteins.
Career Highlights
Burks is currently associated with Exelixis, Inc., a company renowned for its commitment to drug discovery and development. His expertise in the biotechnological realm enhances the company's innovative capacity. Throughout his career, Burks has focused on the intersection of genetic engineering and therapeutic application, emphasizing the role of TWIK channel proteins in the advancement of pest management strategies.
Collaborations
In his journey, Christian Burks has collaborated with notable colleagues such as Andrew Roy Buchman and Helen Louise Francis-Lang. These collaborations have fostered a productive environment, contributing to impactful research and developments within the field.
Conclusion
Christian Burks stands out as a pioneering inventor in the biotechnology sector. His patent on invertebrate TWIK channels exemplifies the innovative spirit and practical applications of his work in modern science. With continued advancements and collaborations, Burks is positioned to further influence pest management and therapeutic strategies through his significant contributions to genetic research and development.